Press Releases

Mithra’s EGM Approves Warrant Plan for LDA Capital
23 July 2020
EN FR

Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Mexico
14 July 2020
EN FR

Publication of a Transparency Notification Received from Alychlo NV
10 July 2020
EN FR

Publication of a Transparency Notification Received from Ogesip Invest SA
9 July 2020
EN FR

Mithra Signs LSA for Commercialization of Myring™ in France, Poland and United Kingdom
6 July 2020
EN FR

Mithra Announces FDA Filing Acceptance of New Drug Application for Estelle® in the US
24 June 2020
EN FR

Information on the Total Number of Voting Rights (Denominator)
23 June 2020
EN FR

Notice of Extraordinary Shareholders’ Meeting on 22th July 2020 Regarding Proposed Warrant Plans
19 June 2020
EN FR

Mithra Successfully Raises EUR 65 Million By Means of a Private Placement via an Accelerated Bookbuild Offering
18 June 2020
EN FR

Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy
18 June 2020
EN FR

Mithra Signs LSA for Commercialization of Tibelia® in Liechtenstein and Switzerland
11 June 2020
EN FR

Mithra Issues First Put Option Notice Under Capital Agreement with LDA Capital
5 June 2020
EN FR